Risk for excessive anticoagulation during hemodialysis is associated with type of vascular access and bedside coagulation testing: Results of a cross-sectional study

BACKGROUND: Recommendations and practice patterns for heparin dosing during hemodialysis show substantial heterogeneity and are scantly supported by evidence. This study assessed the variability in unfractionated heparin (UFH) dosing during hemodialysis and its clinical and biological anticoagulator...

Descripción completa

Detalles Bibliográficos
Autores principales: De Troyer, Marijke, Wissing, Karl Martin, De Clerck, Dieter, Cambier, Marie-Laure, Robberechts, Tom, Tonnelier, Annelies, François, Karlien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794613/
https://www.ncbi.nlm.nih.gov/pubmed/36590973
http://dx.doi.org/10.3389/fmed.2022.1009748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794613/
https://www.ncbi.nlm.nih.gov/pubmed/36590973
http://dx.doi.org/10.3389/fmed.2022.1009748

Ejemplares similares